In recent correspondence by Rieder et al. on 8 patients with severe COVID-19 requiring veno-venous-extracorporeal membrane oxygenation (the CYCOV study), patients who received extracorporeal cytokine adsorption had lower IL-6 levels after 72 h of treatment compared to patients without cytokine adsorption (17). The gene discussed is IL6; the disease is COVID-19.